Peter J Allen

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients
    Peter J Allen
    Memorial Sloan Kettering Cancer Center, USA
    Ann Surg 244:572-82. 2006
  2. doi request reprint Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 210:744-52, 752-5. 2010
  3. ncbi request reprint Pancreatic adenocarcinoma: putting a hump in survival
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 205:S76-80. 2007
  4. ncbi request reprint The management of cystic lesions of the pancreas
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Adv Surg 41:211-28. 2007
  5. doi request reprint Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:636-41. 2011
  6. doi request reprint Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Ann Surg 250:754-60. 2009
  7. doi request reprint The management of intraductal papillary mucinous neoplasms of the pancreas
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surg Oncol Clin N Am 19:297-310. 2010
  8. doi request reprint Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience
    Patrick S Wolf
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 216:41-9. 2013
  9. doi request reprint Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors
    Kaori Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:1609-17. 2012
  10. doi request reprint Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Flavio G Rocha
    Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hepatology 56:1352-60. 2012

Detail Information

Publications97

  1. pmc A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients
    Peter J Allen
    Memorial Sloan Kettering Cancer Center, USA
    Ann Surg 244:572-82. 2006
    ..To define a group of patients with pancreatic cysts who do not require resection...
  2. doi request reprint Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 210:744-52, 752-5. 2010
    ..This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time...
  3. ncbi request reprint Pancreatic adenocarcinoma: putting a hump in survival
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 205:S76-80. 2007
  4. ncbi request reprint The management of cystic lesions of the pancreas
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Adv Surg 41:211-28. 2007
    ..Continued improvements in cross-sectional imaging and endoscopic techniques and further investigation into markers in the serum and cyst fluid should allow better identification of mucinous subtypes...
  5. doi request reprint Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:636-41. 2011
    ..The efficacy of laparoscopic celiac plexus block (CPB) in patients with unresectable pancreatic cancer has not been reported...
  6. doi request reprint Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Ann Surg 250:754-60. 2009
    ....
  7. doi request reprint The management of intraductal papillary mucinous neoplasms of the pancreas
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surg Oncol Clin N Am 19:297-310. 2010
    ..This article describes the radiologic and histopathologic classification system of IPMN; the biologic behavior of these lesions, and the diagnostic testing most commonly used, and discusses the current treatment controversies...
  8. doi request reprint Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience
    Patrick S Wolf
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 216:41-9. 2013
    ..This study investigates the effect of preoperative chemotherapy for CRCLM on nontumoral liver histology and perioperative outcomes in a contemporary cohort...
  9. doi request reprint Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors
    Kaori Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:1609-17. 2012
    ..The most clinically important adverse event after HAIPC with floxuridine (FUDR) is biliary sclerosis (BS). Little is known about the etiology of BS...
  10. doi request reprint Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Flavio G Rocha
    Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hepatology 56:1352-60. 2012
    ..Given their significant risk of harboring invasive carcinoma, they should be treated with complete resection...
  11. doi request reprint The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients
    Kenichi Matsuo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 215:343-55. 2012
    ..Complete resection of hilar cholangiocarcinoma (HCCA) is a critical determinant of long-term survival. This study validates a previously reported preoperative clinical T staging system for determining resectability of HCCA...
  12. doi request reprint Pancreas and liver resection in Jehovah's Witness patients: feasible and safe
    Ioannis T Konstantinidis
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
    J Am Coll Surg 217:1101-7. 2013
    ..Jehovah's Witness (JW) patients undergoing liver or pancreas surgery represent a challenging ethical and medical problem, with few reports about their optimal management...
  13. doi request reprint Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases
    Kenneth Cardona
    Department of Surgery, Division of Hepatopancreatobiliary Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:148-54. 2013
    ..This study analyzes the prognostic relevance of pathologic details of the primary colorectal tumor in patients undergoing hepatic resection for CRLM...
  14. doi request reprint Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma
    Shishir K Maithel
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg Oncol 15:3512-20. 2008
    ..Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined...
  15. doi request reprint Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 254:851-6. 2011
    ..The principle aim of this study was to compare outcomes in patients receiving modern systemic chemotherapy with or without HAI-FUDR...
  16. doi request reprint Synchronous resection of primary and liver metastases for neuroendocrine tumors
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:4270-7. 2012
    ..Surgical approach is an accepted approach for metastatic neuroendocrine tumors (NET), but the safety and effectiveness of synchronous liver metastases resection with primary and/or locally recurrent NET is unclear...
  17. doi request reprint Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2908-16. 2012
    ..We sought to assess the influence of obesity and body fat distribution on pathologic characteristics and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma...
  18. doi request reprint CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases
    Adam C Yopp
    Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 19:S339-46. 2012
    ....
  19. pmc The role of laparoscopic staging in patients with incidental gallbladder cancer
    Jean M Butte
    Departments of Surgery Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    HPB (Oxford) 13:463-72. 2011
    ..The role of staging laparoscopy (SL) in patients with incidental gallbladder cancer (IGBC) is ill defined. This study evaluates the utility of SL with the aim of identifying variables associated with disseminated disease (DD)...
  20. doi request reprint Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma
    Adam C Yopp
    Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg 253:968-74. 2011
    ....
  21. doi request reprint Liver angiomyolipomas: a clinical, radiologic, and pathologic analysis of 22 patients from a single center
    Jean M Butte
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Surgery 150:557-67. 2011
    ..The spectrum of presentation, imaging and histologic features, and outcomes were analyzed in all patients treated at Memorial Sloan-Kettering Cancer Center...
  22. doi request reprint Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma
    Kaori Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:675-81. 2010
    ..To examine the importance of adequate lymph node sampling in staging of extrahepatic bile duct cancer (EHBDCA)...
  23. pmc Vascular inflow control during hemi-hepatectomy: a comparison between intrahepatic pedicle ligation and extrahepatic vascular ligation
    Francesco E D'Amico
    Department of Surgery, Hepatopancreatobiliary Division, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    HPB (Oxford) 15:449-56. 2013
    ..Intrahepatic pedicle ligation (IPL) is an alternative to extrahepatic portal dissection (EPD). Although IPL has been well described, concern has arisen over a possible association with increased complication rates...
  24. doi request reprint Failure patterns in resected pancreas adenocarcinoma: lack of predicted benefit to SMAD4 expression
    Jordan M Winter
    Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA
    Ann Surg 258:331-5. 2013
    ..To determine whether SMAD4 expression is associated with recurrence pattern after resection for pancreatic ductal adenocarcinoma (PDA)...
  25. doi request reprint Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2643-51. 2012
    ..Adrenocortical carcinoma (ACC) liver metastases (LM) represent a therapeutic challenge, and it is unclear whether resection is justified. This study assesses long-term outcome and prognostic factors after liver resection for metastatic ACC...
  26. doi request reprint Is port site resection necessary in the surgical management of gallbladder cancer?
    Ajay V Maker
    Division of Surgical Oncology, Department of Surgery, University of Illinois at Chicago, Chicago, IL, USA
    Ann Surg Oncol 19:409-17. 2012
    ..In selected patients with incidental gallbladder carcinoma (GBCA) diagnosed after laparoscopic cholecystectomy (LC), definitive resection is warranted. Port site excision has been advocated but remains controversial...
  27. doi request reprint Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades
    Jordan M Winter
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:169-75. 2012
    ..The purpose of this study was to evaluate whether these improvements could be identified in a cohort of patients who underwent resection for pancreatic cancer at a single institution over three decades...
  28. doi request reprint Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases
    Shishir K Maithel
    Department of Surgery, Division of Surgical Oncology, Emory University, Atlanta, GA 10065, USA
    Surgery 151:162-70. 2012
    ..The prognostic relevance of variations in expression of specific tumor genes in colorectal cancer liver metastases (CRCLMs) in patients treated with resection and modern chemotherapy is not known...
  29. doi request reprint Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries
    Jean M Butte
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 212:50-61. 2011
    ..This study analyzed GBCA patients treated at centers in 3 countries. The aim was to assess for location-specific differences in presentation and outcomes, which might suggest differences in pathogenesis or disease biology...
  30. doi request reprint A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified
    James J Mezhir
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Gastrointest Surg 13:2163-9. 2009
    ..Preoperative biliary drainage (PBD) prior to pancreaticoduodenectomy (PD) continues to be routine in many centers despite retrospective and randomized data showing that PBD increases perioperative infectious complications...
  31. pmc Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Am Coll Surg 212:590-600; discussion 600-3. 2011
    ..The aim of this study was to assess the change in presentation and management of pancreatic cystic lesions evaluated at a single institution over 15 years...
  32. doi request reprint Solid pseudopapillary tumors of the pancreas. Clinical features, surgical outcomes, and long-term survival in 45 consecutive patients from a single center
    Jean M Butte
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Gastrointest Surg 15:350-7. 2011
    ..The aim of this study was to define the natural history and compare patient and tumor factors between patients with malignant and non-malignant disease...
  33. doi request reprint Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis
    Kai A Bickenbach
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
    Ann Surg Oncol 20:2029-34. 2013
    ..The purpose of this study was to analyze the resectability rate and role of diagnostic laparoscopy in a contemporary cohort...
  34. doi request reprint Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy
    Lianne K Cavell
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Gastroenterol 108:1168-73. 2013
    ..Our objective was to compare surgical outcomes of patients undergoing pancreaticoduodenectomy (PD) with SEMS in place vs. plastic endoscopic stents (PES) and no stents (NS)...
  35. doi request reprint Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome
    George A Poultsides
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 19:2797-804. 2012
    ..Histologically, dominant response patterns include fibrosis, necrosis and/or acellular mucin, but some of these changes can appear without previous chemotherapy and their individual correlation with outcome is unknown...
  36. doi request reprint Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease
    John B Ammori
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Surg Oncol 106:953-8. 2012
    ..Some patients considered for HAI have evidence of minimal extrahepatic disease (EHD), and the role of HAI in these situations is unknown...
  37. doi request reprint The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surgery 151:518-25. 2012
    ..Cystic pancreatic endocrine neoplasms (CPENs) are uncommon tumors with uncertain disease biology and ill-defined diagnostic features...
  38. pmc High-grade dysplasia of the cystic duct margin in the absence of malignancy after cholecystectomy
    Kai A Bickenbach
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    HPB (Oxford) 13:865-8. 2011
    ..A total of 750,000 cholecystectomies are performed annually in the USA. No data exist on patients with microscopic high-grade dysplasia at the cystic duct margin and the associated incidence of cholangiocarcinoma...
  39. ncbi request reprint Pancreatic adenocarcinoma: the actual 5-year survivors
    Cristina R Ferrone
    Department of Surgery, Memorial Sloan Kettering Cancer Center, Howard 1223, 1275 York Avenue, New York, NY 10021, USA
    J Gastrointest Surg 12:701-6. 2008
    ..Actual 5-year survival is rarely described, and factors associated with long-term survival are not well described...
  40. doi request reprint Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas
    Ajay V Maker
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 18:199-206. 2011
    ..IPMN dysplasia may be associated with mucin protein (MUC) expression and histopathologic subtype. We hypothesize that MUC expression in cyst fluid and serum can identify lesions with high risk of malignancy...
  41. doi request reprint Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence
    Matthew J Weiss
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:285-94. 2013
    ..This study evaluates the effect of hepatic pedicle clamping [i.e., Pringle maneuver (PM)] on survival and recurrence following hepatic resection for colorectal liver metastasis (CRLM)...
  42. doi request reprint Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011
    Camilo Correa-Gallego
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 215:616-21. 2012
    ..Most published series span decades and do not reflect contemporary practice. This study analyzes the rate, management, and outcomes of PPH during a recent 5-year period...
  43. pmc Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days?
    John M Lyons
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    HPB (Oxford) 14:469-75. 2012
    ..The optimal surgical management of patients found to have unresectable pancreatic cancer at open exploration remains unknown...
  44. doi request reprint Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer
    Shishir K Maithel
    Department of Surgery, Division of Surgical Oncology, Emory University, Atlanta, GA, USA
    J Am Coll Surg 210:31-8. 2010
    ..CT imaging frequently detects subcentimeter pulmonary nodules (SPN) in patients undergoing resection of colorectal cancer liver metastases. Their clinical significance is unknown...
  45. doi request reprint Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution
    Camilo Correa-Gallego
    From the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
    Ann Surg 258:1051-8. 2013
    ..The current study sought to evaluate the evolution of practice over the last 5 years...
  46. doi request reprint Long-term outcomes following tumor ablation for treatment of bilateral colorectal liver metastases
    Paul J Karanicolas
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    JAMA Surg 148:597-601. 2013
    ..Ablative therapies extend the capability of delivering potentially curative treatment for bilateral hepatic colorectal metastases...
  47. pmc Changes in the management of benign liver tumours: an analysis of 285 patients
    James J Mezhir
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    HPB (Oxford) 15:156-63. 2013
    ..Benign liver tumours (BLTs) are common and their management remains controversial. This study assesses the safety of a selective management approach...
  48. doi request reprint Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma
    Ryan C Fields
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:3311-20. 2012
    ..Here, the authors describe their experience with a large cohort of patients who were treated at a single institution to describe patterns of recurrence after curative therapy...
  49. ncbi request reprint Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer
    Michael G House
    Department of Surgery and Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Gastrointest Surg 11:1549-55. 2007
    ..The purpose of this study was to evaluate the significance of pathologic nodal assessment and extent of nodal metastases on patient outcome in patients with pancreatic adenocarcinoma...
  50. pmc Feasibility and yield of screening in relatives from familial pancreatic cancer families
    Emmy Ludwig
    Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Am J Gastroenterol 106:946-54. 2011
    ..In this study, we investigate whether screening at-risk relatives of familial pancreatic cancer (FPC) patients is safe and has significant yield...
  51. ncbi request reprint Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma
    Jason S Gold
    Department of Surgery, VA Boston Healthcare System Brigham and Women s Hospital, West Roxbury, Massachusetts, USA
    Ann Surg Oncol 14:3159-67. 2007
    ..We tested the utility of a nomogram created for determining disease-specific survival (DSS) after R0 resection of gastric cancer in estimating DSS for patients with resected duodenal cancer...
  52. pmc Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response
    Adam C Yopp
    Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Ann Surg Oncol 18:2192-9. 2011
    ....
  53. doi request reprint Use of intraoperative ablation as an adjunct to surgical resection in the treatment of recurrent colorectal liver metastases
    Anand Govindarajan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 444 E 68th Street, Room C887, New York, NY 10065, USA
    J Gastrointest Surg 15:1168-72. 2011
    ..To evaluate the role of intraoperative ablation as an adjunct to resection in patients with recurrent colorectal liver metastases (rCLM)...
  54. doi request reprint Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases
    David J Gallagher
    Department of Medicine, Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY, USA
    Ann Surg Oncol 16:1844-51. 2009
    ..We investigated the relation between response to neoadjuvant chemotherapy and overall survival (OS) in patients with colorectal liver metastases (CLM)...
  55. ncbi request reprint Impact of steatosis on perioperative outcome following hepatic resection
    David A Kooby
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:1034-44. 2003
    ..Steatosis alone should not preclude aggressive hepatic resection for neoplasms when indicated; however, patients with marked steatosis undergoing large resections should still be approached with due caution...
  56. doi request reprint Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution
    John B Ammori
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:2901-7. 2013
    ..This study analyzes the combination of HAI and systemic chemotherapy for treating unresectable CRLM, focusing on conversion to complete R/A...
  57. doi request reprint Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer
    Jean M Butte
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:5414-23. 2012
    ..In this study, the authors examined recurrence patterns and survival after resection of SLMRC...
  58. doi request reprint Ablation of perivascular hepatic malignant tumors with irreversible electroporation
    T Peter Kingham
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Am Coll Surg 215:379-87. 2012
    ..This study evaluated the safety and short-term outcomes of IRE to ablate perivascular malignant liver tumors...
  59. pmc Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy
    Maeve A Lowery
    Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 16:1714-20. 2011
    ..We present a series of 40 consecutive cases of ACC of the pancreas treated at Memorial Sloan-Kettering Cancer Center, with an emphasis on evaluation of activity of new therapeutic agents...
  60. doi request reprint Pitfalls in avoiding operation for autoimmune pancreatitis
    Peter A Learn
    Department of Surgery, San Antonio Military Medical Center, Ft Sam Houston, TX 78234, USA
    Surgery 150:968-74. 2011
    ..Despite improved clinical characterization, autoimmune pancreatitis is often still diagnosed only after a major operative procedure. This study seeks to elucidate the circumstances that contribute to an inaccurate preoperative diagnosis...
  61. doi request reprint Defining surgical indications for type I gastric carcinoid tumor
    Rebecca A Gladdy
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 16:3154-60. 2009
    ..The management of this indolent disease is controversial. The aim of this study was to evaluate endoscopic surveillance (ES) compare with surgical resection (SR) for type I GC...
  62. ncbi request reprint Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
    Cristina R Ferrone
    Department of Surgery, Memorial Sloan Kettering Cancer Center, Howard 1223, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 25:5609-15. 2007
    ..This study compares the prognostic value of a simplified staging and grading system with the WHO system in a large single-institution study...
  63. ncbi request reprint Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY10021, USA
    J Am Coll Surg 201:57-65. 2005
    ..Successful use of a hepatic arterial infusion pump requires a low technical complication rate. We evaluated the complications and longterm durability of these devices at our institution...
  64. doi request reprint Laparoscopic distal pancreatectomy: evolution of a technique at a single institution
    Shiva Jayaraman
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 211:503-9. 2010
    ..The pancreas remains an organ for which routine laparoscopic resection is uncommon...
  65. ncbi request reprint The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma
    Cristina R Ferrone
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 10:1347-53. 2006
    ..23% negative; P=0.006). In this study, patients who underwent resection in the presence of positive peritoneal cytology and absence of other identifiable metastatic disease had a similar survival as other patients with stage IV disease...
  66. pmc Does pre-operative chemoradiation for initially unresectable or borderline resectable pancreatic adenocarcinoma increase post-operative morbidity? A case-matched analysis
    Raphael L C Araujo
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    HPB (Oxford) 15:574-80. 2013
    ..Neoadjuvant chemoradiation therapy for locally unresectable and borderline resectable pancreatic cancer may allow some patients to a undergo a resection, but whether or not this increases post-operative morbidity remains unclear...
  67. doi request reprint Laparoscopic versus open liver resection: a matched-pair case control study
    Kaori Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Gastrointest Surg 13:2276-83. 2009
    ..The aim of this study was to conduct a comparative outcome study between LLR and matched-pair open liver resections (OLR)...
  68. pmc T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases
    Steven C Katz
    Division of Surgical Oncology, Department of Surgery, Roger Williams Medical Center, Providence, RI, USA
    HPB (Oxford) 12:674-83. 2010
    ..Tumour-infiltrating lymphocytes (TILs) have been shown to predict survival in numerous malignancies. The importance of TILs in primary pancreatic neuroendocrine tumours (NETs) and NET liver metastases (NETLMs) has not been defined...
  69. pmc Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas
    Ajay V Maker
    Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Illinois 60612, USA
    Clin Cancer Res 17:1502-8. 2011
    ..We hypothesized that dysplasia in IPMN invokes an immunogenic/proinflammatory microenvironment that can be identified by cyst fluid cytokine levels...
  70. ncbi request reprint Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Gastrointest Surg 12:270-8. 2008
    ..The purpose of this study was to examine the preoperative patient and radiographic factors that are associated with operative morbidity after pancreaticoduodenectomy...
  71. doi request reprint Allergies, obesity, other risk factors and survival from pancreatic cancer
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Cancer 127:2412-9. 2010
    ..62, 95% CI: 0.76-3.44). The mechanisms underlying the association between history of allergies and improved survival are unknown. These novel results need to be confirmed in other studies...
  72. pmc An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions
    Maeve A Lowery
    Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Oncologist 16:1397-402. 2011
    ....
  73. ncbi request reprint Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer
    Vivian E Strong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 203:129-31. 2006
  74. doi request reprint Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study
    Vivian E Strong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 16:1507-13. 2009
    ..The aim of this study is to compare technical feasibility and oncologic efficacy of totally laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma...
  75. ncbi request reprint Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients
    Peter J Allen
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:970-7. 2003
    ..Selection criteria identified in this study (symptoms, cyst size, solid component, and septations) and the utilization of new imaging techniques allow the creation of treatment plans for these patients that can be prospectively tested...
  76. pmc Genome wide analysis and clinical correlation of chromosomal and transcriptional mutations in cancers of the biliary tract
    George Miller
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Exp Clin Cancer Res 28:62. 2009
    ..The pathogenesis of biliary cancers is ill-defined. This study investigates changes in gene expression and copy number in biliary cancers and correlates these changes with anatomical site of origin, histopathology and outcome...
  77. doi request reprint Single-incision laparoscopic liver resection
    Sebastien Gaujoux
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Surg Endosc 25:1489-94. 2011
    ..Various abdominal procedures have already been performed via single-port access, but to date, single-port-access surgery has never been reported for liver resection...
  78. doi request reprint Relationship between intraoperative fluid administration and perioperative outcome after pancreaticoduodenectomy: results of a prospective randomized trial of acute normovolemic hemodilution compared with standard intraoperative management
    Mary Fischer
    Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, USA
    Ann Surg 252:952-8. 2010
    ..The aim of this study was to determine whether acute normovolemic hemodilution (ANH), an established blood conservation technique, reduces perioperative allogeneic transfusions in patients undergoing PD...
  79. ncbi request reprint The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas
    John C Mansour
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 10:1354-60. 2006
    ..We do not believe whole body FDG-PET to be essential in the evaluation of cystic lesions of the pancreas...
  80. doi request reprint Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver
    Joseph P Erinjeri
    Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cardiovasc Intervent Radiol 33:610-4. 2010
    ....
  81. ncbi request reprint Merkel cell carcinoma: prognosis and treatment of patients from a single institution
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021 e mail
    J Clin Oncol 23:2300-9. 2005
    ..Merkel cell carcinoma (MCC) is an uncommon cutaneous malignancy. Most reports consist of single-institution experiences of fewer than 30 patients. The natural history of MCC is poorly defined...
  82. pmc BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma
    Cristina R Ferrone
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 27:433-8. 2009
    ....
  83. pmc Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality
    Udo Rudloff
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:2229-36. 2010
    ..Tissue banking has become a major initiative at many oncology centers. The influence of warm ex-vivo ischemia times, storage times, and biobanking protocols on RNA integrity and subsequent microarray data is not well documented...
  84. doi request reprint Five hundred patients with Merkel cell carcinoma evaluated at a single institution
    Ryan C Fields
    Department of Surgery, Barnes Jewish Hospital, Washington University School of Medicine, Louis, MO, USA
    Ann Surg 254:465-73; discussion 473-5. 2011
    ..To identify factors associated with survival in Merkel cell carcinoma (MCC)...
  85. ncbi request reprint Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:109-15; discussion 116-7. 2003
    ....
  86. ncbi request reprint Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system
    Stephen R Grobmyer
    Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 204:356-64. 2007
    ..Improving surgical quality of care requires accurate reporting of postoperative complications...
  87. doi request reprint Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas
    Satish Nagula
    Gastroenterology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    J Gastrointest Surg 14:1997-2003. 2010
    ..The role of cyst fluid CEA as a marker for either malignancy or malignant progression is uncertain...
  88. pmc Studying cancer in minorities: a look at the numbers
    Sara H Olson
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 117:2762-9. 2011
    ..The authors aimed to understand how population characteristics affect the numbers of minority cancer cases in Surveillance, Epidemiology, and End Results (SEER) regions...
  89. ncbi request reprint Colon sentinel lymph node mapping: practical surgical applications
    Alexander Stojadinovic
    Department of Surgery, Division of Surgical Oncology, Walter Reed Army Medical Center, Washington, DC, USA
    J Am Coll Surg 201:297-313. 2005
  90. doi request reprint Synchronous epithelial and neuroendocrine cancers of the pancreas: case series of a rare occurrence
    Derek G Power
    Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Clin Colorectal Cancer 10:146-50. 2011
    ..We report 2 cases with a purpose of discussing management strategies, prognosis, and potential etiologies of this rare presentation...
  91. doi request reprint Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005
    Yael Vin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 207:490-8. 2008
    ..Anastomotic fistula, leak, and abscess are common complications of pancreatectomy. The goal of this study was to describe our current management and outcomes of clinically significant postpancreatectomy fistula, leak, and abscess...
  92. ncbi request reprint Current status of hepatic resection
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Adv Surg 37:29-49. 2003
    ..Advances in laparoscopic equipment and techniques will undoubtedly expand the use of these techniques and is the next frontier in hepatic resectional surgery...
  93. doi request reprint Randomized clinical trials in pancreatic adenocarcinoma
    Udo Rudloff
    Department of Surgery, Memorial Sloan Kettering Cancer Center, Hepatopancreaticobiliary Service, C 896, 1275 York Avenue, NY 10021, USA
    Surg Oncol Clin N Am 19:115-50. 2010
    ..All trials included in this article are Ia or Ib. Types of treatment reviewed include surgery, chemotherapy, molecular therapy, radiation therapy, immunotherapy, and palliative therapy...
  94. ncbi request reprint The management of variant arterial anatomy during hepatic arterial infusion pump placement
    Peter J Allen
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 9:875-80. 2002
    ..The success of hepatic arterial infusion pump (HAIP) placement in patients with variant arterial anatomy has not been well described...
  95. pmc Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma
    Alexander Stojadinovic
    Departments of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 235:92-8. 2002
    ..To analyze a large, single-institution experience with routine frozen section (FS) of the sentinel lymph node (SLN) in patients with primary cutaneous melanoma...
  96. ncbi request reprint The surgical management of metastatic melanoma
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 9:762-70. 2002
    ....
  97. ncbi request reprint The role of surgery for patients with metastatic melanoma
    Peter J Allen
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Curr Opin Oncol 14:221-6. 2002
    ..Resection of metastases in patients who recur within one-year, who present with multiple lesions, and who present with disease that cannot be completely resected, will not result in long-term survival...